RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
Two Pappas Ventures’ Portfolio companies make FierceMedicalDevices’ 2012 Fierce 15 list: CardioDx and TyRx
News | 10. 02. 2012
FierceMedicalDevices named two Pappas Ventures’ portfolio companies to the 2012 Fierce 15 list, the inaugural list of the most innovative and exciting medical device companies. CardioDx is a cardiovascular molecular diagnostics company based in Palo Alto and TyRx is a New Jersey device company developing a range of drug-eluting implantable devices.
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.